2001
CTOS Annual Meeting Posters— Biology
GENE EXPRESSION
IN LIPOMA, HIBERNOMA, AND LIPOSARCOMA
Keith M Skubitz, Edward C Cheng, Denis R Clohisy, Roby
C Thompson, Carlos J Manivel, Amy P Skubitz
University of Minnesota
OBJECTIVE: Malignant transformation is thought to be associated
with changes in the expression of a number of genes, and this alteration
in gene expression is felt to be critical to the development of the
malignant phenotype. In many cases, the progression to malignant transformation
is associated with the sequential acquisition of multiple mutations.
Sarcomas represent a diverse group of tumors felt to be derived from
cells of mesenchymal origin. Marked heterogeneity exists in the biological
behavior of sarcomas, even within histologic subtypes of sarcomas.
In an effort to better understand the biology of sarcomas, we are
examining gene expression using the Affymetrix microarray technology.
METHODS: In this study, the expression of ~60,000 genes/ESTs
in lipomas, hibernomas, intra-muscular lipomas, and liposarcomas
was determined by Gene Logic. Differences in gene expression were
quantified as the fold change in gene expression in lipomas compared
with hibernoma, intra-muscular lipoma, atypical lipomatous tumor,
and liposarcoma.
RESULTS: Nine genes were expressed greater than 20 fold
(1 greater than 70 fold) more in lipomas than in lipomatosis, and
4 were expressed greater than 20 fold more in lipomatosis. Twelve
genes were expressed greater than 20 fold (3 greater than 80 fold)
more in lipoma than in hibernoma, and 13 were expressed greater
than 20 fold more in hibernoma. Interestingly, the thyroid hormone
responsive "spot 14" was more highly expressed in lipoma. Eight
genes were expressed greater than 50 fold (3 greater than 80 fold)
more in lipoma than in intra-muscular lipoma. Seven genes were expressed
greater than 20 fold more in lipoma than in liposarcoma, and 1 was
expressed greater than 20 fold more in liposarcoma.
CONCLUSION: We conclude that differences in gene expression
may help differentiate among subtypes of sarcomas, and may also
yield clues to the pathophysiology of this heterogeneous group of
tumors.
|